Article
SMARCB1 loss creates patient-specific <i>MYC</i> topologies that drive malignant rhabdoid tumor growth
2022-11-22
Abstract excerpt
Malignant rhabdoid tumor (MRT) is a highly malignant and often lethal childhood cancer. MRTs are genetically defined by bi-allelic inactivating mutations in SMARCB1 , a member of the BRG1/BRM-associated factors (BAF) chromatin remodeling complex. Mutations in BAF complex members are common in human cancer, yet their contribution to tumorigenesis remains in many cases poorly understood. Here, we studied derailed r...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0907f649-15c6-534b-bd0d-4a992ec6a51a
- DOI
- 10.1101/2022.11.21.516939
